Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agnes Barna

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
European Journal of Haematology|January 12, 2021
Myelomonocytic skewing in chronic myelomonocytic leukemia: phenotypic, molecular and biologic features and impact on survivalKlaus Geissler, Eva Jäger, Agnes Barna, et al.
European Journal of Haematology|May 10, 2016
In vitro and in vivo effects of JAK2 inhibition in chronic myelomonocytic leukemiaKlaus Geissler, Eva Jäger, Agnes Barna, et al.
BMC Research Notes|September 9, 2015
cFinder: definition and quantification of multiple haplotypes in a mixed sampleNorbert Niklas, Julia Hafenscher, Agnes Barna, et al.
International Journal of Molecular Sciences|May 3, 2016
Quantitative Analysis of Mutant Subclones in Chronic Myeloid Leukemia: Comparison of Different Methodological ApproachesSandra Preuner, Agnes Barna, Florian Frommlet, et al.
European Journal of Haematology|March 17, 2022
Multistep pathogenesis of chronic myelomonocytic leukemia in patientsKlaus Geissler, Eva Jäger, Agnes Barna, et al.
International Journal of Molecular Sciences|August 27, 2020
Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic LeukemiaKlaus Geissler, Eva Jäger, Agnes Barna, et al.
Cancers|July 18, 2020
Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like PhenotypeSonja Heibl, Bettina Gisslinger, Eva Jäger, et al.
European Journal of Haematology|May 17, 2021
Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemiaSigrid Machherndl-Spandl, Eva Jäger, Agnes Barna, et al.
International Journal of Molecular Sciences|April 30, 2020
Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 PatientsKlaus Geissler, Eva Jäger, Agnes Barna, et al.
Wiener Klinische Wochenschrift|July 20, 2019
The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) : A representative and useful real-life data source for further biomedical researchKlaus Geissler, Eva Jäger, Agnes Barna, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Journal of Haematology|January 12, 2021
Myelomonocytic skewing in chronic myelomonocytic leukemia: phenotypic, molecular and biologic features and impact on survivalKlaus Geissler, Eva Jäger, Agnes Barna, et al.
European Journal of Haematology|May 10, 2016
In vitro and in vivo effects of JAK2 inhibition in chronic myelomonocytic leukemiaKlaus Geissler, Eva Jäger, Agnes Barna, et al.
BMC Research Notes|September 9, 2015
cFinder: definition and quantification of multiple haplotypes in a mixed sampleNorbert Niklas, Julia Hafenscher, Agnes Barna, et al.
International Journal of Molecular Sciences|May 3, 2016
Quantitative Analysis of Mutant Subclones in Chronic Myeloid Leukemia: Comparison of Different Methodological ApproachesSandra Preuner, Agnes Barna, Florian Frommlet, et al.
European Journal of Haematology|March 17, 2022
Multistep pathogenesis of chronic myelomonocytic leukemia in patientsKlaus Geissler, Eva Jäger, Agnes Barna, et al.
International Journal of Molecular Sciences|August 27, 2020
Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic LeukemiaKlaus Geissler, Eva Jäger, Agnes Barna, et al.
Cancers|July 18, 2020
Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like PhenotypeSonja Heibl, Bettina Gisslinger, Eva Jäger, et al.
European Journal of Haematology|May 17, 2021
Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemiaSigrid Machherndl-Spandl, Eva Jäger, Agnes Barna, et al.
International Journal of Molecular Sciences|April 30, 2020
Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 PatientsKlaus Geissler, Eva Jäger, Agnes Barna, et al.
Wiener Klinische Wochenschrift|July 20, 2019
The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) : A representative and useful real-life data source for further biomedical researchKlaus Geissler, Eva Jäger, Agnes Barna, et al.
Pageof 1